Company finds partner for cancer treatment product


  • By
  • | 3:37 p.m. June 11, 2015
  • Tampa Bay-Lakeland
  • Share

TAMPA -- Oragenics Inc. is trading above a dollar for the first time since the end of March after the medical product acceleration company announced an expanded collaboration agreement with Intrexon Corp. to develop and market a new medication geared toward cancer patients.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content